Jennifer Viera active positions
Companies | Position | Start | End |
---|---|---|---|
ENANTA PHARMACEUTICALS, INC. | Investor Relations Contact | 31/12/2022 | - |
Public Communications Contact | 31/12/2022 | - |
Career history of Jennifer Viera
Former positions of Jennifer Viera
Companies | Position | Start | End |
---|---|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
TETRAPHASE PHARMACEUTICALS, INC. | Investor Relations Contact | - | - |
Public Communications Contact | - | - |
Statistics
International
United States | 4 |
Operational
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ENANTA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Tetraphase Pharmaceuticals, Inc.
Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Viera
- Experience